These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1508692)

  • 1. Repression of the basal c-fos promoter by wild-type p53.
    Kley N; Chung RY; Fay S; Loeffler JP; Seizinger BR
    Nucleic Acids Res; 1992 Aug; 20(15):4083-7. PubMed ID: 1508692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and mapping of the fosB gene. FosB downregulates the activity of the fosB promoter.
    Lazo PS; Dorfman K; Noguchi T; Mattéi MG; Bravo R
    Nucleic Acids Res; 1992 Jan; 20(2):343-50. PubMed ID: 1741260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product.
    Santhanam U; Ray A; Sehgal PB
    Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7605-9. PubMed ID: 1652755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of the p53-induced repression on thymidine kinase promoter by single p53-binding sequence.
    Yuan JN; Liu BH; Lee H; Shaw YT; Chiou ST; Chang WC; Lai MD
    Biochem Biophys Res Commun; 1993 Mar; 191(2):662-8. PubMed ID: 8384849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wild-type murine p53 represses transcription from the murine c-myc promoter in a human glial cell line.
    Moberg KH; Tyndall WA; Hall DJ
    J Cell Biochem; 1992 Jun; 49(2):208-15. PubMed ID: 1400626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gene product p53 is involved in the regulation of activity of the c-fos proto-oncogene promotor].
    Vikhanskaia FL; Pospelova TV; Volkov IV; Kukushkin AN; Svetlikova SB; Poslepov VA
    Dokl Akad Nauk SSSR; 1991; 321(4):846-9. PubMed ID: 1806357
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor-derived p53 mutant C174Y is a gain-of-function mutant which activates the fos promoter and enhances colony formation.
    Preuss U; Kreutzfeld R; Scheidtmann KH
    Int J Cancer; 2000 Oct; 88(2):162-71. PubMed ID: 11004663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The core promoter region of the P-glycoprotein gene is sufficient to confer differential responsiveness to wild-type and mutant p53.
    Zastawny RL; Salvino R; Chen J; Benchimol S; Ling V
    Oncogene; 1993 Jun; 8(6):1529-35. PubMed ID: 8502478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a p53-dependent negative response element in the bcl-2 gene.
    Miyashita T; Harigai M; Hanada M; Reed JC
    Cancer Res; 1994 Jun; 54(12):3131-5. PubMed ID: 8205530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The c-fos proto-oncogene is a target for transactivation by the p53 tumor suppressor.
    Elkeles A; Juven-Gershon T; Israeli D; Wilder S; Zalcenstein A; Oren M
    Mol Cell Biol; 1999 Apr; 19(4):2594-600. PubMed ID: 10082525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA polymerase II promoter-proximal pausing upregulates c-fos gene expression.
    Fivaz J; Bassi MC; Pinaud S; Mirkovitch J
    Gene; 2000 Sep; 255(2):185-94. PubMed ID: 11024278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of p53 at the casein kinase II site selectively regulates p53-dependent transcriptional repression but not transactivation.
    Hall SR; Campbell LE; Meek DW
    Nucleic Acids Res; 1996 Mar; 24(6):1119-26. PubMed ID: 8604347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CROC-1 encodes a protein which mediates transcriptional activation of the human FOS promoter.
    Rothofsky ML; Lin SL
    Gene; 1997 Aug; 195(2):141-9. PubMed ID: 9305758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53-dependent repression of the human MCL-1 gene encoding an anti-apoptotic member of the BCL-2 family: the role of Sp1 and of basic transcription factor binding sites in the MCL-1 promoter.
    Pietrzak M; Puzianowska-Kuznicka M
    Biol Chem; 2008 Apr; 389(4):383-93. PubMed ID: 18208354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A c-fos/Estrogen receptor fusion protein promotes cell cycle progression and proliferation of human cancer cell lines.
    Crowe DL; Brown TN; Kim R; Smith SM; Lee MK
    Mol Cell Biol Res Commun; 2000 Apr; 3(4):243-8. PubMed ID: 10891399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta negatively modulates proliferation and c-fos expression of the human endometrial adenocarcinoma cell line HEC-1-A.
    Bergman CA; Talavera F; Christman GM; Baker VV; Roberts JA; Menon KM
    Gynecol Oncol; 1997 Apr; 65(1):63-8. PubMed ID: 9103392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene.
    Chen J; Lin J; Levine AJ
    Mol Med; 1995 Jan; 1(2):142-52. PubMed ID: 8529093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth of HeLa S3 cells cotransfected with plasmids containing a c-fos gene under the control of the SV40 promoter complex, pRSVcat, and G418 resistance.
    Pai SR; Bird RC
    Biochem Cell Biol; 1992 May; 70(5):316-23. PubMed ID: 1323304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of mutant p53 expression on human 15-lipoxygenase-promoter activity and murine 12/15-lipoxygenase gene expression: evidence that 15-lipoxygenase is a mutator gene.
    Kelavkar UP; Badr KF
    Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4378-83. PubMed ID: 10200270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repression of interleukin-2 and interleukin-4 promoters by tumor suppressor protein p53.
    Pesch J; Brehm U; Staib C; Grummt F
    J Interferon Cytokine Res; 1996 Aug; 16(8):595-600. PubMed ID: 8877730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.